These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Wolk A; Andersson SO; Mantzoros CS; Trichopoulos D; Adami HO Lancet; 2000 Dec; 356(9245):1902-3. PubMed ID: 11130391 [TBL] [Abstract][Full Text] [Related]
5. Making sense of PSA. Thompson IM Health News; 2001 Apr; 7(4):3. PubMed ID: 11303477 [No Abstract] [Full Text] [Related]
6. Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk. Nam RK; Trachtenberg J; Jewett MA; Toi A; Evans A; Emami M; Narod SA; Pollak M Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1270-3. PubMed ID: 15894684 [TBL] [Abstract][Full Text] [Related]
7. [Insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) as serum markers of prostate cancer]. Matsubara A; Nakamoto T; Usui T Nihon Rinsho; 2000 Jul; 58 Suppl():157-62. PubMed ID: 11022706 [No Abstract] [Full Text] [Related]
8. Prostate cancer screening. Mannello F; Gazzanelli G Lancet; 2001 Apr; 357(9263):1202. PubMed ID: 11379564 [No Abstract] [Full Text] [Related]
12. Inverse relation between prostate-specific antigen and insulin-like growth factor-binding protein 3 in bone metastases and serum of patients with prostate cancer. Smith GL; Doherty AP; Mitchell H; Hanham IW; Christmas TJ; Epstein RJ Lancet; 1999 Dec; 354(9195):2053-4. PubMed ID: 10636379 [TBL] [Abstract][Full Text] [Related]
13. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening. Oliver SE; Holly J; Peters TJ; Donovan J; Persad R; Gillatt D; Pearce A; Hamdy FC; Neal DE; Gunnell D Urology; 2004 Aug; 64(2):317-22. PubMed ID: 15302487 [TBL] [Abstract][Full Text] [Related]
14. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study. Borugian MJ; Spinelli JJ; Sun Z; Kolonel LN; Oakley-Girvan I; Pollak MD; Whittemore AS; Wu AH; Gallagher RP Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):252-4. PubMed ID: 18199733 [No Abstract] [Full Text] [Related]
15. Serum insulin-like growth factor I/free prostate specific antigen (IGF-I/fPSA) ratio enhances prostate cancer detection in men with total PSA 4.0-10.0 ng/ml. Zhigang Z; Jieming L; Su L; Wenlu S J Surg Oncol; 2007 Jul; 96(1):54-61. PubMed ID: 17345593 [TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role? Jackson BR Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565 [No Abstract] [Full Text] [Related]